Your browser doesn't support javascript.
loading
Analysis of Normal Hematopoietic Stem and Progenitor Cell Contents in Childhood Acute Leukemia Bone Marrow.
Balandrán, Juan Carlos; Vadillo, Eduardo; Dozal, David; Reyes-López, Alfonso; Sandoval-Cabrera, Antonio; Laffont-Ortiz, Merle Denisse; Prieto-Chávez, Jessica L; Vilchis-Ordoñez, Armando; Quintela-Nuñez Del Prado, Henry; Mayani, Héctor; Núñez-Enríquez, Juan Carlos; Mejía-Aranguré, Juan Manuel; López-Martínez, Briceida; Jiménez-Hernández, Elva; Pelayo, Rosana.
Affiliation
  • Balandrán JC; Oncology Research Unit, Oncology Hospital, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Departamento de Biomedicina Molecular, CINVESTAV, México City, México.
  • Vadillo E; Oncology Research Unit, Oncology Hospital, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Departamento de Biomedicina Molecular, CINVESTAV, México City, México.
  • Dozal D; Hospital para el Niño, Instituto Materno Infantil del Estado de México, México.
  • Reyes-López A; Hospital Infantil de México "Federico Gómez", Mexico City, Mexico.
  • Sandoval-Cabrera A; Hospital para el Niño, Instituto Materno Infantil del Estado de México, México.
  • Laffont-Ortiz MD; Hospital para el Niño, Instituto Materno Infantil del Estado de México, México.
  • Prieto-Chávez JL; Unidad de Investigación Médica en, Hospital de Especialidades, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Vilchis-Ordoñez A; Hospital Infantil de México "Federico Gómez", Mexico City, Mexico.
  • Quintela-Nuñez Del Prado H; Unidad Médica de Alta Especialidad, "Dr. Victorio de la Fuente Narvaez", Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Mayani H; Oncology Research Unit, Oncology Hospital, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Núñez-Enríquez JC; Unidad de Epidemiología de Investigación Clínica Hospital de Pediatría, Instituto Mexicano del Seguro Social, México City, México.
  • Mejía-Aranguré JM; Unidad de Epidemiología de Investigación Clínica Hospital de Pediatría, Instituto Mexicano del Seguro Social, México City, México.
  • López-Martínez B; Hospital Infantil de México "Federico Gómez", Mexico City, Mexico.
  • Jiménez-Hernández E; Hospital Pediátrico Moctezuma, México City, México.
  • Pelayo R; Oncology Research Unit, Oncology Hospital, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Electronic address: rosanapelayo@gmail.com.
Arch Med Res ; 47(8): 629-643, 2016 11.
Article in En | MEDLINE | ID: mdl-28476191
ABSTRACT
BACKGROUND AND

AIMS:

Childhood acute leukemias (AL) are characterized by the excessive production of malignant precursor cells at the expense of effective blood cell development. The dominance of leukemic cells over normal progenitors may result in either direct suppression of functional hematopoiesis or remodeling of microenvironmental niches, contributing to BM failure and AL-associated mortality. We undertook this study to investigate the contents and functional activity of hematopoietic stem/progenitor cells (HSPC) and their relationship to immune cell production and risk status in AL pediatric patients.

METHODS:

Multiparametric flow cytometry of BM aspirates was performed to classify AL on the basis of lineage and differentiation stages and to analyze HSPC and immune cell frequencies. Controlled co-culture systems were conducted to evaluate functional lineage potentials of primitive cells. Statistical correlations and inter-group significant differences were established.

RESULTS:

Among 113 AL BM aspirates, 26.5% corresponded to ProB, 19.5% to PreB and 32% contain ProB and PreB differentiation stages, whereas nearly 9% of the cases were T- and 13% myeloid-lineage leukemias. We identified ProB-ALL as the subtype endowed with the highest relative contents of HSPC, whereas T-ALL and PreB-ALL showed a critically reduced size of both HSC and MLP compartments. Notably, lower cell frequencies of HSPC in ProB-ALL correlated to high-risk prognosis at disease debut.

CONCLUSIONS:

HSPC abundance at initial diagnosis may aid to predict the clinical course of ALL and to identify high-risk patients. A clearer understanding of their population dynamics and functional properties in the leukemia setting will potentially pave the way for targeted therapies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stem Cells / Bone Marrow / Bone Marrow Cells / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: Arch Med Res Journal subject: MEDICINA Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stem Cells / Bone Marrow / Bone Marrow Cells / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: Arch Med Res Journal subject: MEDICINA Year: 2016 Document type: Article